Suppr超能文献

动脉内输注顺铂和博来霉素对子宫颈癌细胞周期的影响。

The influence of intra-arterial infusion of cisplatinum and bleomycin on the cell cycle in uterine cervical carcinoma.

作者信息

Kigawa J, Kanamori Y, Morishita K, Ishihara H, Minagawa Y, Maeda K

机构信息

Department of Obstetrics and Gynecology, Tottori University School of Medicine.

出版信息

Nihon Gan Chiryo Gakkai Shi. 1990 Nov 20;25(11):2665-9.

PMID:1703556
Abstract

We examine the influence of CDDP and BLM on the cell cycle in the patients with uterine cervical cancer. Specimens were obtained from 8 cases of local recurrent uterine cervical cancer which were treated with CDDP and BLM bolus infusions into bilateral internal iliac arteries. Except for two patients who showed no response according to the criteria of the National Cancer Institute (NCI), the other patients exhibited partial response (PR). The concentrations of BLM and CDDP were 0.83 +/- 0.05 microgram/g and 2.9 +/- 0.54 microgram/g in the tumor tissues 24 hours after treatment. The peak values of the drug concentrations in serum, which were observed at 30 min for both drugs, were 0.92 +/- 0.12 microgram/ml BLM and 1.02 +/- 0.65 microgram/ml CDDP and the concentrations of the drugs decreased rapidly in the serum. The higher levels of CDDP and BLM were retained in the tumor tissue 24 hours after treatment, than in serum. Changes in DNA content determined by flow cytometry, revealed that proliferation indices (PI) increased after treatment only in PR cases. The mean increase in the ratio was 0.10 +/- 0.015. The BrdU staining showed that cells in S phase increased in tumor tissues. Labeling indices increased from 0.10 +/- 0.04 to 0.18 +/- 0.05. These results suggested that cell synchronization was induced by CDDP and BLM in vivo. PI seemed a useful parameter for measuring drug sensitivity.

摘要

我们研究了顺铂(CDDP)和博来霉素(BLM)对子宫颈癌患者细胞周期的影响。标本取自8例局部复发性子宫颈癌患者,这些患者接受了双侧髂内动脉大剂量注射CDDP和BLM治疗。除两名根据美国国立癌症研究所(NCI)标准显示无反应的患者外,其他患者均表现出部分缓解(PR)。治疗后24小时,肿瘤组织中BLM和CDDP的浓度分别为0.83±0.05微克/克和2.9±0.54微克/克。两种药物在血清中的药物浓度峰值均在30分钟时观察到,分别为0.92±0.12微克/毫升BLM和1.02±0.65微克/毫升CDDP,血清中药物浓度迅速下降。治疗后24小时,肿瘤组织中保留的CDDP和BLM水平高于血清。通过流式细胞术测定DNA含量的变化,发现仅在PR病例中治疗后增殖指数(PI)增加。比值的平均增加为0.10±0.015。BrdU染色显示肿瘤组织中S期细胞增加。标记指数从0.10±0.04增加到0.18±0.05。这些结果表明,CDDP和BLM在体内诱导了细胞同步化。PI似乎是测量药物敏感性的一个有用参数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验